Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture

被引:14
|
作者
Schubert, Susanna [1 ,2 ]
Brehm, Walter [1 ,3 ]
Hillmann, Aline [1 ]
Burk, Janina [1 ,2 ]
机构
[1] Univ Leipzig, Saxonian Incubator Clin Translat SIKT, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany
[2] Univ Leipzig, Inst Physiol, Fac Vet Med, Tierkliniken 7, D-04103 Leipzig, Germany
[3] Univ Leipzig, Large Anim Clin Surg, Fac Vet Med, Tierkliniken 21, D-04103 Leipzig, Germany
关键词
mesenchymal stromal cells; adipose; horse; human; serum-free; cell culture; immunophenotyping; STEM-CELLS; XENO-FREE; BONE-MARROW; INTERNATIONAL-SOCIETY; CLINICAL-TRIALS; UMBILICAL-CORD; EXPANSION; DIFFERENTIATION; TISSUE; PROLIFERATION;
D O I
10.1002/cyto.a.23240
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
For clinical applications of multipotent mesenchymal stromal cells (MSCs), serum-free culture is preferable to standardize cell products and prevent contamination with pathogens. In contrast to human MSCs, knowledge on serum-free culture of large animal MSCs is limited, despite its relevance for preclinical studies and development of veterinary cellular therapeutics. This study aimed to evaluate the suitability of a commercially available serum-free human MSC medium for culturing equine adipose-derived MSCs in comparison with human adipose MSCs. Enzyme-free isolation by explant technique and expansion of equine and human cells in the serum-free medium were feasible. However, serum-free culture altered the morphology and complicated handling of equine MSCs, with cell aggregation and spontaneous detachment of multilayers, compared to culture in standard medium supplemented with fetal bovine serum. Furthermore, proliferation and the surface immunophenotype of equine cells were more variable compared to the controls and appeared to depend on the lot of the serum-free medium. Particularly the expression of CD90 was different between experimental groups (P<0.05), with lower percentages of CD90(+) cells found in equine MSC samples cultured in serum-free medium (5.21-83.40%) compared to standard medium (86.20-99.50%). Additionally, small subpopulations expressing MSC exclusion markers such as CD14 (0.28-11.60%), CD34 (0.00-9.87%), CD45 (0.35-10.50%), or MHCII (0.00-3.67%) were found in equine samples after serum-free culture. In contrast, human samples displayed a more consistent morphology and a consistent CD29(+) (98.60-99.90%), CD73(+) (94.60-98.40%), CD90(+) (99.60-99.90%), and CD105(+) (97.40-99.80%) immunophenotype after culture in serum-free medium. The obtained data demonstrate that the serum-free medium was suitable for human MSC culture but did not lead to entirely satisfactory results in equine MSCs. This underlines that requirements regarding serum-free culture conditions are species-specific, indicating aneed for serum-free media to be optimized for MSCs from relevant animal species. (c) 2017 International Society for Advancement of Cytometry
引用
收藏
页码:60 / 72
页数:13
相关论文
共 50 条
  • [1] Animal serum-free culture conditions for human multipotent mesenchymal stromal cells (MSC)
    Holzworth, C
    Kordowich, S
    Isensee, G
    Handgretinger, R
    Müller, I
    [J]. KLINISCHE PADIATRIE, 2006, 218 (03): : 188 - 188
  • [2] Characterization of Canine Adipose-Derived Mesenchymal Stromal/Stem Cells in Serum-Free Medium
    Liu, Zhuoming
    Screven, Rudell
    Boxer, Lynne
    Myers, Michael J.
    Devireddy, Lax R.
    [J]. TISSUE ENGINEERING PART C-METHODS, 2018, 24 (07) : 399 - 411
  • [3] A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells
    Devireddy, Laxminarayana R.
    Myers, Michael
    Screven, Rudell
    Liu, Zhuoming
    Boxer, Lynne
    [J]. PLOS ONE, 2019, 14 (02):
  • [4] Ultrastructural features of human adipose-derived multipotent mesenchymal stromal cells
    Manea, Claudiu Marius
    Rusu, Mugurel Constantin
    Constantin, Daniel
    Manoiu, Valentina Mariana
    Moldovan, Lucia
    Jianu, Adelina Maria
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2014, 55 (04): : 1363 - 1369
  • [5] Generation and characterization of a functional human adipose-derived multipotent mesenchymal stromal cell line
    Burk, Janina
    Holland, Heidrun
    Lauermann, Anne F.
    May, Tobias
    Siedlaczek, Philipp
    Charwat, Verena
    Kasper, Cornelia
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2019, 116 (06) : 1417 - 1426
  • [6] Evaluation of a Serum-Free Medium for Human Epithelial and Stromal Cell Culture
    Caneparo, Christophe
    Chabaud, Stephane
    Fradette, Julie
    Bolduc, Stephane
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [7] A NOVEL XENO/SERUM-FREE MEDIUM TO SUPPORT THE ISOLATION AND EXPANSION OF HUMAN ADIPOSE-DERIVED MESENCHYMAL STEM CELLS
    Fitzgerald, J. C.
    Shaw, G.
    Jones, D.
    Murphy, M.
    Barry, F.
    [J]. CYTOTHERAPY, 2021, 23 (05) : S63 - S63
  • [8] Effect assessment of a type of xeno-free and serum-free human adipose-derived mesenchymal stem cells culture medium by proliferation and differentiation capacities
    Chen, Shanshan
    Meng, Li
    Wang, Shanshan
    Xu, Yan
    Chen, Wenbin
    Wei, Jianfeng
    [J]. CYTOTECHNOLOGY, 2023, 75 (05) : 403 - 420
  • [9] Effect assessment of a type of xeno-free and serum-free human adipose-derived mesenchymal stem cells culture medium by proliferation and differentiation capacities
    Shanshan Chen
    Li Meng
    Shanshan Wang
    Yan Xu
    Wenbin Chen
    Jianfeng Wei
    [J]. Cytotechnology, 2023, 75 : 403 - 420
  • [10] Ultrastructure of human adipose-derived multipotent mesenchymal stromal cells loaded with synthetic microcapsules
    Daminova, A. G.
    Rizvanov, A. A.
    Litvinova, L. S.
    Shupletsova, V. V.
    Khaziakhmatova, O. G.
    Yurova, K. A.
    Malashchenko, V. V.
    Todosenko, N. M.
    Timin, A. S.
    Kudryavtseva, V.
    Pokrovskaya, L.
    Korotkova, E.
    Litvinov, R. I.
    Sukhorukov, G. B.
    Gow, A. J.
    Atochina-Vasserman, E. N.
    Khlusov, I. A.
    [J]. HUMAN GENE THERAPY, 2018, 29 (12) : A73 - A74